# One-in-Ten Prescriptions of Medicinal Cannabis from Single Source – The Christian Institute > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/medicinal-cannabis-prescribing-concentration-concerns/ > **Published:** 2026-04-01T16:05:02-04:00 | **Last Modified / Clinically Audited:** 2026-09-29T00:10:13-04:00 > **Clinical Summary:** Explore the implications of medicinal cannabis prescribing concentration and its impact on clinical ethics, market access, and patient care. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Prescribing PatternsMarket AccessClinical EthicsProduct Selection[Healthcare Policy](https://cedclinic.com/cannabis-legalization-in-canada-new-opportunities/) Why This Matters Market concentration in medicinal cannabis prescribing raises clinical concerns about treatment standardization, supply chain resilience, and potential conflicts of interest. Understanding prescriber patterns helps identify whether clinical decisions are driven by evidence-based protocols or commercial relationships. Clinical Summary Data indicates significant market concentration in UK medicinal cannabis prescribing, with one supplier capturing a disproportionate share of prescriptions. This pattern could reflect either superior clinical outcomes, effective marketing to prescribers, or structural market advantages rather than purely clinical considerations. The concentration raises questions about product diversity, pricing competition, and clinical decision-making independence in this emerging therapeutic area. Dr. Caplan’s Take “Market concentration this extreme should make us ask hard questions about whether prescribing patterns reflect clinical superiority or commercial influence. Patients deserve access to the full range of evidence-based options, not just the most aggressively marketed ones.” Clinical Perspective 🧠 Clinicians should evaluate whether their cannabis product selection is based on clinical evidence, patient response data, and cost-effectiveness rather than vendor relationships or marketing influence. Patients may benefit from asking their providers about alternative products and the specific rationale for product selection. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20One-in-ten%20prescriptions%20of%20medicinal%20cannabis%20from%20single%20source%20-%20The%20Christia...%20%40drcaplan&url=https%3A//www.christian.org.uk/news/one-in-ten-prescriptions-of-medicinal-cannabis-from-single-source/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.christian.org.uk/news/one-in-ten-prescriptions-of-medicinal-cannabis-from-single-source/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20One-in-ten%20prescriptions%20of%20medicinal%20cannabis%20from%20single%20source%20-%20The%20Christia...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.christian.org.uk/news/one-in-ten-prescriptions-of-medicinal-cannabis-from-single-source/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.christian.org.uk/news/one-in-ten-prescriptions-of-medicinal-cannabis-from-single-source/](https://www.christian.org.uk/news/one-in-ten-prescriptions-of-medicinal-cannabis-from-single-source/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news update?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news_update) - [What key areas does this cannabis clinical update cover?](#What_key_areas_does_this_cannabis_clinical_update_cover) - [Why is this information important for healthcare providers?](#Why_is_this_information_important_for_healthcare_providers) - [What does “Notable Clinical Interest” mean in this context?](#What_does_8220Notable_Clinical_Interest8221_mean_in_this_context) - [How does this update relate to clinical practice?](#How_does_this_update_relate_to_clinical_practice) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news update? This update has been assigned CED Clinical Relevance #70 with a “Notable Clinical Interest” rating. This indicates emerging findings or policy developments that are worth monitoring closely by healthcare professionals. #### What key areas does this cannabis clinical update cover? The update focuses on four main areas: prescribing patterns, market access, clinical ethics, and product selection. These topics are essential for clinicians working with [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) patients. #### Why is this information important for healthcare providers? This represents emerging findings and policy developments in the [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) field. Healthcare providers need to stay informed about evolving prescribing practices and clinical considerations. #### What does “Notable Clinical Interest” mean in this context? It signifies that the information contains developments worth close monitoring by medical professionals. This rating suggests the content may impact clinical decision-making or [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) practices. #### How does this update relate to clinical practice? The update addresses practical aspects of [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) including how doctors prescribe, patient access to treatments, ethical considerations, and product selection criteria. These factors directly influence [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and treatment outcomes. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “One-in-ten prescriptions of medicinal cannabis from single source – The Christian Institute”, “url”: “https://www.christian.org.uk/news/one-in-ten-prescriptions-of-medicinal-cannabis-from-single-source/”, “datePublished”: “2026-04-01T16:00:13Z”, “about”: “one ten prescriptions medicinal cannabis single”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Should clinics prescribe medicinal cannabis that they also supply? We asked 5 experts](https://cedclinic.com/cannabis-prescribing-ethics-clinics-supply-conflict/) Explore expert opinions on the ethical considerations of clinics prescribing medicinal cannabis products they supply. [Read expert insights](https://cedclinic.com/cannabis-prescribing-ethics-clinics-supply-conflict/) [Medicinal cannabis crackdowns are actually working – Medical Republic](https://cedclinic.com/medicinal-cannabis-crackdowns-impact-access/) An analysis of regulatory crackdowns and their effects on the medicinal cannabis market and prescribing practices. [Learn about regulatory impacts](https://cedclinic.com/medicinal-cannabis-crackdowns-impact-access/) [Cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) is more than a scientific pursuit—it's a pathway to better health, informed … Discover how ongoing [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) informs clinical practice and policy development for improved patient outcomes. Explore cannabis research ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).